Related Experiment Video
Updated: Apr 5, 2026
A 3D Spheroid Model for Glioblastoma
Published on: April 9, 2020
Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence
Aleksandra Franovic1, Kathryn C Elliott1, Laetitia Seguin1
1Department of Pathology, University of California, San Diego, La Jolla, California. Moores Cancer Center, University of California, San Diego, La Jolla, California.
Abstract:
Integrin αvβ3 has been implicated as a driver of aggressive and metastatic disease, and is upregulated during glioblastoma progression. Here, we demonstrate that integrin αvβ3 allows glioblastoma cells to counteract senescence through a novel tissue-specific effector mechanism involving recruitment and activation of the cytoskeletal regulatory kinase PAK4. Mechanistically, targeting either αvβ3 or PAK4 led to emergence of a p21-dependent, p53-independent cell senescence phenotype. Notably, glioblastoma cells did not exhibit a similar requirement for either other integrins or additional PAK family members. Moreover, αvβ3/PAK4 dependence was not found to be critical in epithelial cancers. Taken together, our findings established that glioblastomas are selectively addicted to this pathway as a strategy to evade oncogene-induced senescence, with implications that inhibiting the αvβ3-PAK4 signaling axis may offer novel therapeutic opportunities to target this aggressive cancer.
Insights
Glioblastoma cells evade senescence using integrin αvβ3 and PAK4. Targeting this pathway induces senescence, offering a potential new treatment for aggressive brain tumors.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Integrin αvβ3 is linked to aggressive cancers and glioblastoma progression.
- Glioblastoma cells must overcome senescence to proliferate.
- The role of integrin αvβ3 in glioblastoma senescence evasion is not fully understood.
Purpose of the Study:
- To investigate the mechanism by which integrin αvβ3 facilitates glioblastoma cell evasion of senescence.
- To identify key molecular players involved in this process.
- To explore the therapeutic potential of targeting this pathway.
Main Methods:
- Investigated the role of integrin αvβ3 and PAK4 in glioblastoma cell senescence.
- Utilized molecular and cellular assays to target αvβ3 and PAK4.
- Analyzed the resulting senescence phenotype, including p21 and p53 dependency.
Main Results:
- Integrin αvβ3 recruits and activates PAK4 in glioblastoma cells, enabling senescence evasion.
- Inhibition of αvβ3 or PAK4 triggers a p21-dependent, p53-independent senescence phenotype.
- This dependence is specific to glioblastoma and not observed in epithelial cancers.
Conclusions:
- Glioblastomas are uniquely reliant on the αvβ3-PAK4 axis to avoid oncogene-induced senescence.
- This pathway represents a novel therapeutic target for aggressive glioblastoma.
- Inhibiting the αvβ3-PAK4 signaling axis may provide new treatment strategies.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:22PI3K/mTOR/AKT Signaling Pathway
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
01:10Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:11IP3/DAG Signaling Pathway